|
"ll tsai"的相关文件
显示项目 1-5 / 5 (共1页)
1
每页显示[10|25|50]项目
| 中山醫學大學 |
2015-06-01 |
miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
|
CC, Yu;LL, Tsai;ML, Wang;CH, Yu;WL, Lo;YC, Chang;GY, Chiou;MY, Chou;SH, Chiou |
| 中山醫學大學 |
2014-08-25 |
Enhanced chemosensitivity by targeting Nanog in head and neck squamous cell carcinomas.
|
CE, Huang;CC, Yu;FW, Hu;MY, Chou;LL, Tsai |
| 中山醫學大學 |
2013-01 |
Epithelial–mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer
|
PY, Chu; FW, Hu; CC, Yu; LL, Tsai; CH, Yu; BC, Wu; YW, Chen; PI, Huang; WL, Lo |
| 中山醫學大學 |
2012-05 |
Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
|
YP, Yang; YL, Chang; PI, Huang; GY, Chiou; LM, Tseng; SH, Chiou; MH, Chen; MT, Chen; YH, Shih; CH, Chang; CC, Hsu; Hl, Ma; CT, Wang; LL, Tsai; CC, Yu; CJ, Chang |
| 中山醫學大學 |
2011-02-02 |
MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation
|
CC, Yu; YW, Chen; GY, Chiou; LL, Tsai; Huang Pl, Chang CY; LM, Tseng; SH, Chiou; SH, Yen; MY, Chou; PY, Chu; WL, Lo |
显示项目 1-5 / 5 (共1页)
1
每页显示[10|25|50]项目
|
